Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes

In this episode, Dr. Bradley Stein joins the show to discuss findings from his new study titled Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes, featured in the September/October issue of the Journal of Addiction Medicine. Dr. Bradley Stein is a practicing physician and senior physician policy researcher at RAND. His research career has focused on improving access to, quality of, and outcomes from care of individuals with mental health and substance use disorders being treated in community settings. For two decades, Dr. Stein has studied the opioid crisis, serving as principal investigator for numerous federally and privately funded studies. He has published multiple peer-reviewed articles related to studies of opioid use disorder treatment, harm reduction, and the effects of state and federal policies, and he has provided Congressional testimony related to his research on multiple occasions. And his work has been covered by a range of media outlets including the Economist, Washington Post, and New York Times. Article Link: Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes Guest Editorial: Medicaid Unwinding May Have Substantially Disrupted Buprenorphine Treatment

You can listen to Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes online on Radio and Podcast. Open the player on this page to stream the available audio.

Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes is an episode from Addiction Medicine: Beyond the Abstract by Shawn McNeil, MD.

This episode is 16:10 long.

This episode was published on Dec 11, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Addiction Medicine: Beyond the Abstract when more episodes are available from the podcast feed.